Interleukin-6 Role in Plaque Psoriasis Severity

Psoriasis is a long-lasting skin condition that causes inflammation and is influenced by the immune system. It affects a small but significant part of the global population. This study is focused on a specific protein called Interleukin-6 (IL-6) found in the body, which is known to play a role in immune response and inflammation. Researchers are looking into how IL-6 may be linked to the severity of psoriasis, as higher levels of IL-6 have been found in the skin areas affected by psoriasis. Understanding this connection could help improve the treatment and management of psoriasis by targeting IL-6 to reduce disease severity. Participants in this study will not receive any specific treatment, as it is observational. Instead, the study will evaluate the severity of their psoriasis using a tool called the Psoriasis Area and Severity Index (PASI). This index helps categorize participants into different groups based on their condition's severity, from mild to severe. The aim is to see if there is a relationship between IL-6 levels and how severe the psoriasis is. By studying this connection, researchers hope to find better ways to identify and manage severe cases of psoriasis.